AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2012
Nov 6, 2012
33651_dirs_2012-11-05_dd2c9fbc-af2f-4da6-9818-9839c9ef6eaf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2012-11-02
Reporting Person: Hillsberg Sanford (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-02 | Common Stock | G | 20000 | — | Disposed | 136376 | Direct |
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
Jun 2
Report Publication Announcement
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9